feed,title,long_url,short_url
Benzinga,"Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.",https://www.benzinga.com/pressreleases/21/01/g19224286/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acqui,https://j.mp/3ir62Yp
Benzinga,OceanFirst Financial Corp. Declares Quarterly Cash Dividend for Series A Preferred Stock,https://www.benzinga.com/pressreleases/21/01/g19224283/oceanfirst-financial-corp-declares-quarterly-cash-dividend-for-series-a-preferred-stock,https://j.mp/3ixbed9
Benzinga,Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock,https://www.benzinga.com/pressreleases/21/01/g19224281/fulcrum-therapeutics-announces-proposed-public-offering-of-common-stock,https://j.mp/38YuPjx
Benzinga,"Colliers International Group Inc. to Announce Fourth Quarter and Annual Results for 2020 on February 11, 2021",https://www.benzinga.com/pressreleases/21/01/g19224280/colliers-international-group-inc-to-announce-fourth-quarter-and-annual-results-for-2020-on-februar,https://j.mp/3p6aZbK
Benzinga,"Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer",https://www.benzinga.com/pressreleases/21/01/g19224246/fulcrum-therapeutics-announces-promotion-of-christopher-moxham-ph-d-to-chief-scientific-officer,https://j.mp/3qBIEdC
